Rosetta Green

NEW YORK (GenomeWeb) – Roughly two years after it agreed to pay $518 million for Devgen and its portfolio of agricultural RNAi technologies, Syngenta announced this month that it is collaborating with Australian startup Nexgen to develop virus-resistant crop plants through microRNA targeting.

Just days after the acquisition of agricultural microRNA firm Rosetta Green by Monsanto was cleared by Israeli antitrust authorities, Rosetta Green’s former parent from Rosetta Genomics has opposed the deal.

Rosetta Green said this week that it has signed an agreement under which it licensed an undisclosed microRNA from Iowa State University for use in developing plants resistant to nematodes.
Specific terms of the deal were not disclosed.

Rosetta Green announced last week that it has struck a research collaboration with German plant breeding firm KWS to discover microRNAs that can improve sugar beet.

Rosetta Green last week announced that it has successfully completed an experiment producing biologically active human growth hormone from algae.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Green and Bayer CropScience have signed an agreement directed at discovering and characterizing microRNA genes with the potential to improve cotton yields.

Rosetta Green announced this week that it is negotiating a deal under which “one of the world's largest seed companies” would license a “limited” number of microRNAs identified by Rosetta Green as potentially improving key traits within an undisclosed crop plant.

Rosetta Green announced this week that it has successfully altered tobacco plants, which serve as models for corn and soybean plants, to use seawater irrigation.

By Doug Macron
Rosetta Green this week announced that it has inked a strategic research deal with DuPont, its biggest partner to date, to identify microRNAs associated with drought tolerance in corn and soybeans.

Pages

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.